U.S. flag

An official website of the United States government

NM_003560.4(PLA2G6):c.916C>T (p.Arg306Trp) AND Infantile neuroaxonal dystrophy

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 28, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002023201.3

Allele description [Variation Report for NM_003560.4(PLA2G6):c.916C>T (p.Arg306Trp)]

NM_003560.4(PLA2G6):c.916C>T (p.Arg306Trp)

Gene:
PLA2G6:phospholipase A2 group VI [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q13.1
Genomic location:
Preferred name:
NM_003560.4(PLA2G6):c.916C>T (p.Arg306Trp)
HGVS:
  • NC_000022.11:g.38132992G>A
  • NG_007094.3:g.86787C>T
  • NM_001004426.3:c.916C>T
  • NM_001199562.3:c.916C>T
  • NM_001349864.2:c.916C>T
  • NM_001349865.2:c.916C>T
  • NM_001349866.2:c.916C>T
  • NM_001349867.2:c.382C>T
  • NM_001349868.2:c.238C>T
  • NM_001349869.2:c.382C>T
  • NM_003560.4:c.916C>TMANE SELECT
  • NP_001004426.1:p.Arg306Trp
  • NP_001186491.1:p.Arg306Trp
  • NP_001336793.1:p.Arg306Trp
  • NP_001336794.1:p.Arg306Trp
  • NP_001336795.1:p.Arg306Trp
  • NP_001336796.1:p.Arg128Trp
  • NP_001336797.1:p.Arg80Trp
  • NP_001336798.1:p.Arg128Trp
  • NP_003551.2:p.Arg306Trp
  • LRG_1015t1:c.916C>T
  • LRG_1015:g.86787C>T
  • LRG_1015p1:p.Arg306Trp
  • NC_000022.10:g.38528999G>A
  • NG_007094.2:g.77699C>T
Protein change:
R128W
Links:
dbSNP: rs1301929071
NCBI 1000 Genomes Browser:
rs1301929071
Molecular consequence:
  • NM_001004426.3:c.916C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001199562.3:c.916C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349864.2:c.916C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349865.2:c.916C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349866.2:c.916C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349867.2:c.382C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349868.2:c.238C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349869.2:c.382C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003560.4:c.916C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Infantile neuroaxonal dystrophy (NBIA2A)
Synonyms:
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; Seitelberger disease; Infantile neuroaxonal dystrophy 1
Identifiers:
MONDO: MONDO:0024457; MedGen: C0270724; Orphanet: 35069; OMIM: 256600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002305313Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 28, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002305313.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 306 of the PLA2G6 protein (p.Arg306Trp). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PLA2G6-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PLA2G6 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024